Obinutuzumab

ATC L01FA03 · 10 markets · 14 records

Obinutuzumab 10 markets · 14 records Forms

AU 3 records · 3 strengths

1,000 mg/40 mLinjectionGazyva also in GB·US·SG
1,000 mginjectionGAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial also in ES·CN unknown

Records without a stated strength · 1 Gazyva

GB 2 records · 1 strengths

1,000 mg/40 mLinjectionGazyvaro 1000mg/40ml concentrate for solution for infusion vials also in AU·US·SG

ES 2 records · 1 strengths

1,000 mginjectionGAZYVARO also in AU·CN

US 1 records · 1 strengths

1,000 mg/40 mLinjectionGazyva also in AU·GB·SG

CA 1 records · 1 strengths

25 mgliquidGazyva

SG 1 records · 1 strengths

1,000 mg/40 mLinjectionGAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML also in AU·GB·US

CN 1 records · 1 strengths

1,000 mginjection佳罗华奥妥珠单抗 also in AU·ES

TW 1 records · 1 strengths

Records without a stated strength · 1 Gazyva solution for infusion、癌即瓦注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 GAZYVARO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
1,000 mg/40 mLRecorded as: 1 g/40 mL injection	Gazyva	Gazyvaro 1000mg/40ml concentrate for solution for infusion vials	not recorded	Gazyva	GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML	not recorded	not recorded	not recorded	not recorded	not recorded
1,000 mg injection	not recorded	not recorded	not recorded	GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial	not recorded	佳罗华奥妥珠单抗	GAZYVARO	not recorded	not recorded	not recorded
25 mg liquid	not recorded	not recorded	Gazyva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Gazyva	not recorded	not recorded	not recorded	not recorded	GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML	GAZYVARO
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Gazyva solution for infusion 癌即瓦注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.